FUROSEMIDE BAXTER 20 MG2 ML

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

FUROSEMIDE

Доступна с:

DAVID MARGALIT & CO.LTD

код АТС:

C03CA01

Фармацевтическая форма:

SOLUTION FOR INJECTION

состав:

FUROSEMIDE 10 MG/ML

Администрация маршрут:

I.M, I.V

Тип рецепта:

Required

Производитель:

BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, INDIA

Терапевтические области:

FUROSEMIDE

Терапевтические показания :

Furosemide baxter 20mg/2 ml Injection is a potent diuretic indicated for use when a prompt and effective diuresis is required. The Furosemide baxter 20 mg/2 ml injection is appropriate for use in emergencies or when oral therapy is not feasible. Indications include cardiac, pulmonary, hepatic and renal oedema.

Дата Авторизация:

2022-01-31

Характеристики продукта

Anaesthetics, general: Enhanced hypotensive effects.
Anion-exchange
resins:
Colestyramine
and
colestipol
markedly
reduce
the
absorption of furosemide. Administer two to three hours apart.
Aldesleukin: Enhanced hypotensive effect.
Anti-arrhythmics: Toxicity of amiodarone, disopyramide, flecainide and
quinidine is
increased if hypokalaemia occurs. Action of lidocaine and mexilitine
is antagonised
by hypokalaemia.
1.
NAME OF THE MEDICINAL PRODUCT
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_ _
_Adults_
_ _
_Children_: Parenteral doses for children range from 0.5 to 1.5 mg/kg
body weight
daily up to a maximum total daily dose of 20 mg.
4.3
CONTRAINDICATIONS
Each ml contains 10 mg of Furosemide.
3.
PHARMACEUTICAL FORM
Route of administration: intramuscular or intravenous
Furosemide Baxter 20 mg/2 ml
Intramuscular administration must be restricted to exceptional cases
where neither
oral
nor
intravenous
administration
are
feasible.
It
must
be
noted
that
intramuscular injection is not suitable for the treatment of acute
conditions such as
pulmonary oedema.
Furosemide Baxter 20 mg/2 ml Injection is a potent diuretic indicated
for use when
a prompt and effective diuresis is required. The Furosemide Baxter 20
mg/2 ml
injection is appropriate for use in emergencies or when oral therapy
is not feasible.
Indications include cardiac, pulmonary, hepatic and renal oedema.
4. CLINICAL PARTICULARS
Solution for injection.
Intravenous furosemide must be injected or infused slowly; a rate of 4
mg per
minute must not be exceeded. In patients with severe impairment of
renal function
(serum creatinine >5 mg/dl), it is recommended that an infusion rate
of 2.5 mg per
minute is not exceeded.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1
4.1
THERAPEUTIC INDICATIONS
Each 2 ml ampoule contains 20mg of furosemide
It is clear, colourless or almost colourless solution.
To achieve optimum efficacy and suppress counter-regulation, a
continuous
furosemide infusion is generally to be preferred to repeated bo